ENTITY
Stéphane Bancel
Stéphane Bancel
PulseAugur coverage of Stéphane Bancel — every cluster mentioning Stéphane Bancel across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
RELATIONSHIPS
RECENT · PAGE 1/1 · 2 TOTAL
-
AI-developed cancer vaccine shows promise, but high cost raises accessibility concerns · 1 source tracked
Moderna and Merck's personalized mRNA cancer vaccine, Intismeran Autogene, has shown promising results in Phase III clinical trials for melanoma, marking a significant milestone as the first individualized neoantigen th…
-
Merck, Moderna melanoma vaccine shows promise in Phase 3 trial
Merck and Moderna have announced promising results from a Phase 3 clinical trial for their personalized mRNA vaccine, intismeran autogene, when used in combination with Merck's Keytruda immunotherapy for melanoma patien…